Dr. David D. Verdier, MD

Dr. Verdier practices at East Paris Surgical Center - HOPD in Grand Rapids, Michigan.

Dr. Verdier's NPI, 1588637433, was assigned on February 10, 2006. Dr. Verdier graduated from University of Michigan Medical School in 1977. Dr. Verdier holds Michigan license 4301040864.

Dr. Verdier's primary practice is East Paris Surgical Center - HOPD, at 1000 E Paris Ave SE, Grand Rapids, MI 49546.

Dr. Verdier's primary practice is East Paris Surgical Center - HOPD in Grand Rapids, Michigan. Dmand AI also links Dr. Verdier to 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verdier practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Verdier's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Verdier is licensed in Michigan.

CMS data shows 1,957 Medicare services from Dr. Verdier across 14 procedure codes in 2024, for 511 Medicare patients. Medicare paid $225,121 for them.

CMS counts 511 Medicare patients who saw Dr. Verdier in 2024. The largest group is 65 to 74, with 229 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Verdier's median patient age at 74, with 57% women.

In 2024, Dr. Verdier wrote 3,926 Medicare Part D claims for 1,201 patients. 38% of them were for generic drugs. CMS names the drug for 3,833 of them, across 25 drugs with 11 or more claims each, at $271,808 in total drug cost. In 2023, CMS named 4,645 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Verdier for performance year 2024, reported as part of a group. Dr. Verdier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 311 procedures of cataract surgery by Dr. Verdier, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 14 papers to Dr. Verdier, published from 2015 to 2025. 2018 was the busiest year, with 2. The most frequent topics are Fuchs' Endothelial Dystrophy, Corneal Edema and Corneal Endothelial Cell Loss. Dr. Verdier has published most often in Cornea. Dr. Verdier's most frequent co-authors are Mark A. Terry, MD, Francis William Price, MD and Anthony J. Aldave, MD.

Dmand AI links Dr. Verdier to 1 clinical trial. Conditions studied include Herpes Zoster Ophthalmicus and Chickenpox.

CMS Open Payments shows 18 general payments to Dr. Verdier from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. RxSight Inc paid the most, $2,966.

Dr. Verdier graduated from University of Michigan Medical School in 1977.